CREB1 and metabolic syndrome: It is interesting to note that the flavonoid apigenin has previously been reported to improve insulin resistance and dyslipidemia [93], potentiate incretin (GLP-1), modulate the CREB-BNDF signaling pathway, and improve cognition in high-fat diet-induced obese rats [93,94].